Commentary on This Article from Chemoprevention of Head and Neck Cancer with Celecoxib and Erlotinib: Results of a Phase Ib and Pharmacokinetic Study

Autor: Dong M. Shin, Zhuo Georgia Chen, Fadlo R. Khuri, Jennifer R. Grandis, Hyung Ju C. Shin, Sreenivas Nannapaneni, Jonathan J. Beitler, Suresh Ramalingam, Taofeek K. Owonikoko, Charles E. Moore, Amy Y. Chen, William Grist, Melinda Lewis, Rachel Moreno-Williams, Susan Müller, Gabe Sica, Zhengjia Chen, Yang Zhao, Chung S. Yang, Scott A. Kono, Selwyn J. Hurwitz, Nabil F. Saba

Commentary on This Article from Chemoprevention of Head and Neck Cancer with Celecoxib and Erlotinib: Results of a Phase Ib and Pharmacokinetic Study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c271fe78da1fea663b8a9c97910ab1b
https://doi.org/10.1158/1940-6207.22524044.v1

Supplementary Tables 1-2, Figures 1-2 from Fibroblast Growth Factor Receptors Are Components of Autocrine Signaling Networks in Head and Neck Squamous Cell Carcinoma Cells

Autor: Lynn E. Heasley, David Raben, Barbara A. Frederick, Lindsay Marek, Kathryn E. Ware, Brady Bichon, Katherine R. Singleton, Scott A. Kono, Trista K. Hinz, Marianne E. Marshall

PDF file - 168K

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecb3e003d48dff20327f6939a6fb3695
https://doi.org/10.1158/1078-0432.22442463.v1

Role of Nutrition in Squamous Cell Carcinoma of the Head and Neck

Autor: Nabil F. Saba, Kristin Higgins, Fadlo R. Khuri, Scott A. Kono, Omer Kucuk, Ananda S. Prasad, Dong M. Shin

Publikováno v: Otorhinolaryngology: Head and Neck Surgery (2 Volumes)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::56e63f6dfc7c1ccba1c94674aecbf283
https://doi.org/10.5005/jp/books/13036_54

Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results data, 1973 to 2009

Autor: Kristin Higgins, Amy Y. Chen, Scott A. Kono, Dong M. Shin, Nabil F. Saba, Michael Goodman, Kevin C. Ward, William Grist, Jonathan J. Beitler, Taofeek K. Owonikoko, Fadlo R. Khuri, Mark W. El-Deiry, Trad Wadsworth, Benjamin E. Ansa

Publikováno v: Cancer. 119:2602-2610

BACKGROUND Paranasal sinus squamous cell carcinomas (PNSSCC) account for 3% of all head and neck malignancies. There has been little information on the trends in incidence and survival, and no randomized trials have been conducted to guide therapy. M

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f604b6037fd859e35bcc0801affa7cbd
https://doi.org/10.1002/cncr.28108

EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View beyond Cetuximab

Autor: Scott A. Kono, Nabil F. Saba, Sue S. Yom, Missak Haigentz

Publikováno v: Chemotherapy research and practice, vol 2012
Kono, SA; Haigentz, M; Yom, SS; & Saba, N. (2012). EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View beyond Cetuximab.. Chemotherapy research and practice, 2012, 901320. doi: 10.1155/2012/901320. UCSF: Retrieved from: http://www.escholarship.org/uc/item/94z876pk
Chemotherapy Research and Practice

Squamous cell carcinoma of the head and neck (SCCHN) is a prevalent disease both in the United States and worldwide with an overall poor prognosis, in part due to limited activity of existing therapy. Primary therapy is largely dictated by the anatom

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff99c1a032abb7addb9fea80bf2348cf
https://doi.org/10.1155/2012/901320